Dr. Stephen C. Greco, MD

Dr. Greco practices at Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System.

Dr. Greco's NPI, 1659463750, was assigned on September 28, 2006. Dr. Greco graduated from Louisiana State University School of Medicine in New Orleans in 1992. Dr. Greco holds Maryland license D0052153.

Dr. Greco's primary practice is Sibley Memorial Hospital, at 5255 Loughboro Rd NW, Washington, DC 20016 in The District County. The practice phone is (202) 537-4680.

Dr. Greco's primary practice is Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System. Dr. Greco is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Greco to 2 more hospitals, 3 medical groups, 2 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Greco practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Greco's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Greco is licensed in Maryland.

CMS data shows 4,858 Medicare services from Dr. Greco across 24 procedure codes in 2024, for 502 Medicare patients. Medicare paid $1,093,628 for them.

CMS counts 502 Medicare patients who saw Dr. Greco in 2024. The largest group is 75 to 84, with 234 patients. 75% of them have cancer, and 75% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Greco's median patient age at 74, with 14% women.

In 2024, Dr. Greco wrote 319 Medicare Part D claims for 129 patients. 93% of them were for generic drugs. CMS names the drug for 237 of them, across 6 drugs with 11 or more claims each, at $4,626 in total drug cost. In 2023, CMS named 246 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Greco for performance year 2024, reported as part of a group. CMS lists Dr. Greco as offering telehealth.

Dmand AI links 26 papers to Dr. Greco, published from 2016 to 2025. 2018 was the busiest year, with 6. The most frequent topics are Prostatic Neoplasms, Androgen Antagonists and Prostatectomy. Dr. Greco has published most often in Adv Radiat Oncol. Dr. Greco's most frequent co-authors are Channing Paller, MD, Phuoc T. Tran, MD, PhD and Michael Anthony Carducci, MD.

Dmand AI links Dr. Greco to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 2 general payments to Dr. Greco from 1 drug or device company from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $226.

Dr. Greco graduated from Louisiana State University School of Medicine in New Orleans in 1992.